| Term 
 | Definition 
 
        | hyperactivity of airway releases leukotrienes and histamine which cause smooth muscle proliferation, mucous gland hypertrophy, hypersecretion, inflammatory cells, edema, and loss of epithelium |  | 
        |  | 
        
        | Term 
 
        | what are the 3 effector cells in asthma, at what point to they come into play |  | Definition 
 
        | mast cells - immediate response eosinophils - late response
 T cells - chronic response
 |  | 
        |  | 
        
        | Term 
 
        | mast cell: location, 6 things they release |  | Definition 
 
        | 3-5x more in respiratory tract of asthmatic 
 histamine, PGE, PAF, LTD, LTC, LTE
 |  | 
        |  | 
        
        | Term 
 
        | eosinophils: effect, 1 thing they release |  | Definition 
 
        | primary airway effector number in bronchial lavage fluid is related to bronchial hyperreactivity
 
 major basic protein- damages airway epithelium
 |  | 
        |  | 
        
        | Term 
 
        | T cells: effect, 2 thing they release |  | Definition 
 
        | number is proportional to bronchial hyperreactivity 
 releases interleukins
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | intrmittent wheeze, cough, dyspnea, chest tightness
 |  | 
        |  | 
        
        | Term 
 
        | 5 qualifications for intermittent asthma |  | Definition 
 
        | <2d/w <2d/mo nocturnal symptoms
 FEV >80%
 FEV:FEC normal
 SABA use <2d/wk
 |  | 
        |  | 
        
        | Term 
 
        | 5 qualifications for persistant mild asthma |  | Definition 
 
        | >2d/wk 3-4d/mo nocturnal asthma
 FEV >80%
 FEV:FEC normal
 SABA use >2d/wk
 |  | 
        |  | 
        
        | Term 
 
        | 5 qualifications for persistant moderate asthma |  | Definition 
 
        | >2d/wk >2d/mo nocturnal asthma
 FEV >60% <80%
 FEV:FEC <5% reduction
 SABA use daily
 |  | 
        |  | 
        
        | Term 
 
        | 5 qualifications of persistant severe asthma |  | Definition 
 
        | continous symptoms frequent nocturnal symptoms
 FEV <60%
 FEV:FEC >5% reduction
 hospitlized in last year for asthma
 |  | 
        |  | 
        
        | Term 
 
        | 4 ways asthma is diagnosed |  | Definition 
 
        | reversible airway obstruction history of symptoms
 spirometric pulmonary function tests
 methocholine challenge test
 |  | 
        |  | 
        
        | Term 
 
        | 5 goals of asthma therapy |  | Definition 
 
        | normal activity and exercise levels near normal pulmonary function tests
 prevent chronic symptoms
 prevent recurrent exacerbations
 avoid medication SE
 |  | 
        |  | 
        
        | Term 
 
        | 2 types of B2 agonists and their 8 drugs |  | Definition 
 
        | SABA: albuterol, levabuterol, terbutaline, pirbutrol, bitolerol, metaproterenol 
 LABA: salmeterol, formoterol
 |  | 
        |  | 
        
        | Term 
 
        | SABA: onset, duration, usage |  | Definition 
 
        | rapid onset 5-15min inhaled 4-6h duration
 DOC mild asthma, rescue inhaler (not anti-inflammatory
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | relax bronchial smooth muscle (adenylyl cyclase > cAMP > PKA > MLCK > smooth muscle relaxation) 
 stabilizes mast cell membranes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | more in oral/suryp (often used in kids) tremor, tachyarrhythmia, muscle cramps
 |  | 
        |  | 
        
        | Term 
 
        | 2 types of corticosteroids used in asthma and their 6 drugs |  | Definition 
 
        | inhaled: trimacinolone, flutocasone, budesonide 
 systemic- methylprednisone, prednisone, prednisolone
 |  | 
        |  | 
        
        | Term 
 
        | how are steroids used in asthma, time of onset |  | Definition 
 
        | used in moderate to severe asthma with SABA PRN continous prevention
 onset in 4-12h
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stimulate glucocorticoid receptors inhibit inflammation
 reduce mucous production
 increase B2 receptors (increases SABA effectiveness)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | only 10% of steroid reaches lung, 90% is metabolized by first pass if oral 
 increases deposition in lung by decreasing particle velocity and zise
 |  | 
        |  | 
        
        | Term 
 
        | 3 techniques for inhaling and exhaling corticosteroids and their benifits |  | Definition 
 
        | open mouth: decreases particle size but also aim 
 closed mouth: increases aim but increases particle size
 
 nose exhaling: helps with coating of mucosa in allergies
 |  | 
        |  | 
        
        | Term 
 
        | what are 2 propellents used in inhalers |  | Definition 
 
        | chlorofluorocarbon (CFC) hydrofluroalkaline (HFA)
 |  | 
        |  | 
        
        | Term 
 
        | explain how to use an inhaler |  | Definition 
 
        | shake and remove cap exhale slow with pursed lips
 close/open mouth technique
 press once
 slowly inhale over 5 sec
 hold breath 10 sec
 exhale slowly
 wait 1 min before next puff
 |  | 
        |  | 
        
        | Term 
 
        | what is the story for the other drugs (non steroid or B2 agonist) used in asthma |  | Definition 
 
        | the old man and liz needed chrome from chrome mountain, i prayed they throw the line to tio but monte leukast was za first leukast to salute on this |  | 
        |  | 
        
        | Term 
 
        | what are the 9 other drugs used in asthma |  | Definition 
 
        | omalizumab nedcromil
 chromolyn
 ipratropium
 throphylline
 tiotropium
 monteleukast
 zafirleukast
 zileuton
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | monoclonal anti-IgE antibody |  | 
        |  | 
        
        | Term 
 
        | MOA nedcromil and chromolyn |  | Definition 
 
        | inhibit mast degranulation and thus release of histamine and leukotrienes |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | short acting muscarinic antagonist decreases PANS decreasing smooth muscle contraction |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | blocks adenosine (a bronchoconstrictor) decreases PDE III in smooth muscle of bronchi
 decreases PDE IV in inflammatory cells thus decreasing cytokines
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | long acting muscarinic antagonist (with no M2 action) decreases PANS decreasing smooth muscle contraction |  | 
        |  | 
        
        | Term 
 
        | MOA monteleukast and zafirleukast |  | Definition 
 
        | block leukotriene receptors (cys-LT) anti-inflammatory
 causes bronchodilation
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | SE nedcromil, chromolyn 4 |  | Definition 
 
        | anaphylaxis laryngeal edema
 headache
 rash
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | atropine like in high dose |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CNS, CV, increase HR, GI, diuretic like |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | atropine like in high dose |  | 
        |  | 
        
        | Term 
 
        | SE monteleukast, zafirleukast, zileuton |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | severe allergen induced asthma |  | 
        |  | 
        
        | Term 
 
        | use nedcromil, chromolyn 3 |  | Definition 
 
        | adjunct in mild-moderate asthma exercise asthma
 allergen asthma
 |  | 
        |  | 
        
        | Term 
 
        | use ipratopium and tiotropium 2 |  | Definition 
 
        | in combination with B2 agonist (combivent, dunoeb) for COPD pt with B2 intolerance
 never acute use
 |  | 
        |  | 
        
        | Term 
 
        | use monteleukast, zafirleukast, zileuton 2 |  | Definition 
 
        | alternate to steroid in mild asthma 
 adjunct to steroid in severe asthma
 |  | 
        |  | 
        
        | Term 
 
        | age ok for use in monteleukast, zafirleukast, zileuton and administration |  | Definition 
 
        | monteleukast 1yo+ oral zafirleukast 5yo+ oral
 zileuton 10yo + oral
 |  | 
        |  | 
        
        | Term 
 
        | ipratopium and tiotropium: onset, dosing timing, administration |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | throphylline: administration 3, pharmacokinetic quality |  | Definition 
 
        | P450 inhibitor oral, rectal, parentrail
 |  | 
        |  | 
        
        | Term 
 
        | nedcromil, chromolyn: administration, age ok to use, benifits based on age |  | Definition 
 
        | inhaled ok in kids - better than steroid but has not anti-inflammatory effect so steroid is still DOC
 |  | 
        |  | 
        
        | Term 
 
        | omalizumab: age for ok use, administration, dosing timing |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | explain the six stages of asthma treatment |  | Definition 
 
        | 1. SABA PRN 2. LABA daily, SABA PRN
 3. steroid daily, SABA PRN
 4. LABA med dose daily, SABA PRN
 5. LABA lg dose daily, SABA PRN
 6. systemic steroid daily, steroid daily, SABA PRN
 treat for 3mo, if stable step down a level
 |  | 
        |  | 
        
        | Term 
 
        | what is the DOC for childhood asthma, what are 2 alternates |  | Definition 
 
        | steroid inhaled daily monteleukast, cromolyn
 |  | 
        |  | 
        
        | Term 
 
        | define and what is cause of exercise asthma |  | Definition 
 
        | pulmonary function decline (maybe only symptom or seen in 80% asthmatics) caused by hyperventilation of cold air, respiratory heat, and water loss
 |  | 
        |  | 
        
        | Term 
 
        | TX exercise induced asthma |  | Definition 
 
        | <3h exercise: albuterol or terbutaline, chromolyn alternate 
 >3h exercise mild asthma: LABA
 >3h exercise mod asthma: corticosteroid
 |  | 
        |  | 
        
        | Term 
 
        | define and hat is cause of nocturnal astham, 3 signs |  | Definition 
 
        | asthma in sleep or upon waking worse 2-6am due to increased PANS, decreased epinepherine, increased inflammatory mediators, and GERD
 
 morning cough, bronchospasm, esp in expiration (carcadian association)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | LABA corticosteroids if moderate to severe
 |  | 
        |  | 
        
        | Term 
 
        | signs of aspirn induced asthma 3, when would you use aspirin anyways |  | Definition 
 
        | rhinorrhea, wheeze, SOB desensitize for post MI arthritis
 |  | 
        |  | 
        
        | Term 
 
        | what drug should you avoid in asthmatics |  | Definition 
 
        | non-specific BB (even timolol opthalamic) be careful with B1 specific too
 |  | 
        |  | 
        
        | Term 
 
        | causes or associations with COPD 8 |  | Definition 
 
        | asthma cardiac disease
 renal disease
 smoking
 grain
 coal
 asbestos
 pollution
 |  | 
        |  | 
        
        | Term 
 
        | pathological changes in chronic bronchitis |  | Definition 
 
        | increased mucous and glands lead to obstruction, inflammation, edema, infection, bronchial hyperplasia of smooth muscle |  | 
        |  | 
        
        | Term 
 
        | pathological changes in emphysema |  | Definition 
 
        | increased proteases cause inflammation, fibrosis, destruction of alveolar wall and tissue which enlarge air space distal to terminal bronchioles, decrease elastic recoil and support leading to airway collapse without accessory muscle support to increase expiration |  | 
        |  | 
        
        | Term 
 
        | 5 avenules of tx for COPD |  | Definition 
 
        | primary intervention - stop smoking primary therapy - bronchodilators
 corticosteroids
 long term O2 treatment
 immunizations - pneumococcus q6mo
 |  | 
        |  | 
        
        | Term 
 
        | 2 drugs that help stop smoking, their MOA and SE |  | Definition 
 
        | buproprion: sustained release tablet antidepressant (SE suicide) 
 varenicline: nicotinic partial agonist decreases dopamine in mesolimbic tract and thus decreases reinforcement for smoking
 SE: N/V, suicide
 |  | 
        |  | 
        
        | Term 
 
        | what are the indications for long term O2 therapy, what is the timeframe |  | Definition 
 
        | 15-20 h/d reduces mortality 
 PaO2 <55
 right heart failure
 polycythemia
 impaired neuropsychological function with PaO2 <60
 |  | 
        |  | 
        
        | Term 
 
        | what is the drug combination used for bronchodilation in COPD |  | Definition 
 
        | ipratoripum or tiotropium + SABA PRN 
 add throphylline if unable to control
 |  | 
        |  | 
        
        | Term 
 
        | explain how steroids are used in COPD |  | Definition 
 
        | really only benifit asthmatics if not asthmatic, give 20-30mg prednisone for 2-3wks and if successful switch to inhaled steroid
 |  | 
        |  | 
        
        | Term 
 
        | explain the physiology of a cough |  | Definition 
 
        | involves CNS, PNS, bronchial smooth muscle physiological, normal response that helps clear debris
 |  | 
        |  | 
        
        | Term 
 
        | what are the 4 antitussives |  | Definition 
 
        | codiene hydrocodone
 dextromethorphan
 bensonate
 |  | 
        |  | 
        
        | Term 
 
        | what is an expectorant and its MOA |  | Definition 
 
        | guaifensin: increases respiratory fluid output by decreasing viscosity and surface tension |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | isomere of codine levorphanol (L isomere is addicting) acts on medulla to increase threshold equal in effectiveness to codiene
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | GI high dose causes CNS depression
 |  | 
        |  | 
        
        | Term 
 
        | causes of acute rhinitis 6 |  | Definition 
 
        | virus bacteria
 foreign body
 hypothyroid
 pregnancy
 drug induced - medicamentosa
 |  | 
        |  | 
        
        | Term 
 
        | 9 causes of chronic rhinitis |  | Definition 
 
        | allergy - hay fever, perennial vasomotor rhinitis
 tumor
 polyp nasal septal deviation
 enlarged adenoids
 sinusitis
 CSF rinorrhea
 |  | 
        |  | 
        
        | Term 
 
        | 5 modes of tx for rhinitis |  | Definition 
 
        | avoid allergen reversible H1 antagonist
 decongestant
 corticosteroid - inhaled
 cromolyn - inhaled
 |  | 
        |  | 
        
        | Term 
 
        | when should you use reversible H1 antagonist in rhinitis 3 |  | Definition 
 
        | perennial allergic rhinits or conjunctivitis
 |  | 
        |  | 
        
        | Term 
 
        | what are 4 decongestants used in rhinitis |  | Definition 
 
        | pseudophredrine phenhyleephrine
 naphazoline
 oxymetazoline
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | stimulate a1 (symphathomimetrics) often in combo with H1 antagonist
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | rebound congestion upon DC |  | 
        |  |